A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · May 17, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring different methods of processing fat used in breast reconstruction after a mastectomy. The goal is to find out which method helps the fat stay in place better after surgery. The study is currently looking for women aged 65 to 74 who have had previous breast surgery and have enough fat available for grafting. To join, participants should not be pregnant and need to be willing to provide consent.
If you decide to participate, you will be helping researchers understand how different fat processing techniques can improve breast reconstruction outcomes. This study aims to make the surgery more effective for future patients. Your involvement could contribute valuable information about the best ways to use fat grafting in breast surgery.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female;
- • Documented history of previous breast surgery (either complete or partial mastectomy);
- • Available harvest sites for fat grafting as documented by plastic surgeon;
- • BMI \> 20;
- • Anticipated harvested fat volume \> 50cc;
- • Competency and willingness to provide consent
- Exclusion Criteria:
- • Suspected or known to be pregnant
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
David Otterburn, MD
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials